| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918260 | Radiotherapy and Oncology | 2014 | 6 Pages |
Abstract
The use of a PRO tool in lung cancer radiotherapy is feasible, reliable and acceptable to patients. PROs should be integrated in future clinical trials evaluating new radiotherapy approaches to assess toxicity.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Marianna Christodoulou, Paula McCloskey, Nicola Stones, Neil Bayman, Paul Burt, Abbas Chittalia, Margaret Harris, Lip Lee, Laura Pemberton, Hamid Sheikh, Ric Swindell, Corinne Faivre-Finn,